Why the study?
What are the clinical and metabolic effects of escalating doses of intravenous Prostaglandin E1 in healthy men?
What are the clinical and metabolic effects of escalating doses of intravenous Prostaglandin E1 in healthy men?
Intravenous Prostaglandin E1 in healthy men causes significant adverse clinical symptoms like severe headache and abdominal cramps, alongside increased mobilization of free fatty acids and glycerol.
Answers are grounded in this paper and cite their sources.
Severe side effects may limit higher-dose intravenous PGE1; leaves open metabolic effects in clinical populations.
Prostaglandin E 1 (PGE 1 ) was infused intravenously into eight healthy male subjects. The dose was successively increased to the maximal tolerable dose and varied from 0.032 to 0.58 μg/kg/min. When the lower doses were given there were either no clinical effects or only a flushing of the face. When the dose was increased the flushing generally became more intensive and extended to other parts of the body, mainly the arms and hands. In some of the subjects the flushing diminished and even changed to pallor with the highest doses of PGE 1 . All subjects complained of headache which usually became severe. In one of them the headache was unilateral and accompanied by visual symptoms. All subjects developed cramps in the upper part of the abdomen, which generally became so severe that the administration of PGE 1 had to be stopped. Several of the subjects also felt sore in other parts of the body such as the back and legs. The various symptoms disappeared within 15–30 min after the end of the infusion. The arterial levels of free fatty acids in blood plasma increased in all subjects. In several subjects the rise was discontinuous and in two of them a decrease in the level of FFA was seen. The FFA response to PGE 1 was neither related to administered dose nor to clinical effects. Turnover rate studies with labelled palmitic acid showed that the plasma FFA changes were mainly caused by variations in the rate of mobilization of FFA into blood. The plasma levels of glycerol showed the same type of response to PGE 1 as the FFA levels. No significant changes in blood glucose were seen in the seven subjects who were fasting. In one subject who had had breakfast there was a rapid fall in the concentration of blood glucose.
No takes yet. Share an insight, caveat, or question.
Carlson et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: